Menveo 1 vial-a-c-y-w-135-DIP 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQU7B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,212
Award facts
- Contract value 100% obligated
- $13,211.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13.21K delivery order to AmerisourceBergen Drug Corp for MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine product, with an ultimate completion date of January 20, 2026. This non-set-aside award was issued on January 16, 2026, under a firm fixed-price contract structure, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award is issued as a child delivery order under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant $1.0B indefinite delivery contract with DLA Troop Support Medical through December 2026 that serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific vaccine delivery order aligns with AmerisourceBergen's established role as a primary pharmaceutical supplier to the Defense Logistics Agency, demonstrating the company's continued ability to meet federal procurement requirements through open competition and deliver essential medical commodities to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FQU7B?
SPE2DR26FQU7B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FQU7B worth?
The government has obligated $13,212 on SPE2DR26FQU7B.
Is contract SPE2DR26FQU7B an order under another contract?
Yes. SPE2DR26FQU7B is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU7B competed?
The extent of competition for SPE2DR26FQU7B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award